United States Wearable Medical Devices Market Driven by Rising Demand for Remote Patient Monitoring and Preventive Healthcare | Key Players: Koninklijke Philips N.V., Fitbit (Google), Garmin Ltd., Medtronic, Omron among Others

The Wearable Medical Devices Market was valued at US$ 43.56 billion in 2024 and is projected to grow significantly, reaching US$ 239.54 billion by 2033. This growth reflects a robust CAGR of 21.1% during the forecast period from 2025 to 2033.

The U.S. wearable medical devices market was valued at around USD 22 billion in 2024 and is on track to reach over USD 40 billion by 2030, growing at nearly 11% annually. Recent momentum comes from FDA's approval of Dexcom's G7 continuous glucose monitor for 15-day use and new federal initiatives encouraging adoption of wearables for chronic disease management and preventive care.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://www.datamintelligence.com/download-sample/wearable-medical-devices-market?ophp

Wearable medical devices are small, portable electronics engineered to continuously monitor and record health data in real time. They play a vital role in managing chronic illnesses and enhancing patient outcomes by offering round-the-clock health insights. Utilizing advanced technologies such as sensors, Bluetooth connectivity, and cloud computing, these devices empower both individuals and healthcare professionals to make informed, proactive care decisions. The wearable medical devices market is expanding rapidly, fueled by an aging population, a surge in chronic diseases, and a growing focus on health and wellness. This sector represents a transformative shift toward personalized, technology-driven healthcare.

Market Dynamics

Growing Prevalence of Chronic Diseases and Health Awareness
The growing prevalence of chronic diseases like diabetes, cardiovascular conditions, and respiratory issues is driving the demand for wearable medical devices. These devices offer continuous monitoring and proactive management, making them essential for managing health. For example, glucose monitors for diabetes and heart rate trackers for cardiovascular health are becoming common. Increased health awareness among consumers is also fueling the adoption of wearable devices for preventive care.

In the US, 129 million people have at least one chronic disease, with heart disease, cancer, diabetes, obesity, and hypertension being the most common. Chronic diseases are responsible for five of the top 10 leading causes of death, and the prevalence continues to rise. Over 40% of Americans have multiple chronic conditions, contributing to 90% of the $4.1 trillion spent annually on healthcare.

Market Segments:

Based on by Product Type the market is classified into Diagnostic & Monitoring Devices, Therapeutic Devices
Based on by Application the market is segmented as Remote Patient Monitoring, Sports and Fitness Monitoring, Chronic Disease Management, Others

Based on the End User the market segment is sub segmented as Hospitals & Clinics, Homecare Settings, Ambulatory Care Centers, Fitness Centers and Sports Institutes

Unmet Needs:

The wearable medical devices market faces several unmet needs that offer opportunities for innovation. Key challenges include improving the accuracy and reliability of devices, especially for monitoring conditions like blood pressure and glucose levels. Battery life, comfort, and wearability also need improvement to support long-term use. Additionally, better integration with healthcare systems is needed for real-time data sharing. Data privacy and security concerns must be addressed to ensure user trust, while making devices more affordable and accessible for underserved populations is crucial. Finally, more long-term clinical validation is required to prove the effectiveness of these devices in managing health.

Customize Your Scope: https://www.datamintelligence.com/customize/wearable-medical-devices-market

Sustainability:

Continuous advancements in sensors and AI are key to maintaining device effectiveness and appeal.

Adhering to safety and efficacy standards ensures consumer trust and market integrity.

Strong security measures protect sensitive health data, fostering consumer confidence.

Educating users about benefits and proper use encourages widespread adoption.

Seamless integration with healthcare platforms enhances patient care and clinical decision-making.

Regional Overview:

North America is expected to maintain a significant share of the wearable medical devices market, driven by the high prevalence of chronic diseases like diabetes, cardiovascular conditions, and obesity. These health issues create a strong demand for real-time monitoring and management technologies. For Instance, in November 2024, Aktiia expanded into the Canadian market with its continuous blood pressure monitoring bracelet, marking its first move outside of Europe.

Key Market Players:

The major global players in the wearable medical devices market include Koninklijke Philips N.V.; Fitbit (Google); Garmin Ltd.; Medtronic; Omron; Withings; VitalConnect; Polar Electro; Sotera, Inc.; INVIZA Corporation; Dexcom, Inc.; GE HealthCare; CONTEC MEDICAL SYSTEMS CO., LTD; Nanowear Inc. among others.

Emerging Players:

The emerging players in the wearable medical devices market include Nuubo, Activinsights Ltd, Intelesens Ltd, Polar Electro Oy and among others

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=wearable-medical-devices-market

Key Developments:

In April 2025, DexCom, Inc. announced the U.S. Food and Drug Administration (FDA) approval of Dexcom G7 15 Day Continuous Glucose Monitoring System for use in people over the age of 18 with diabetes. This device is clinically proven to lower HbA1c levels and reduce hyper- and hypoglycaemia.

In September 2024, Senseonics Holdings, Inc., and Ascensia Diabetes Care announced that the U.S. Food and Drug Administration (FDA) approved Eversense 365 CGM system. This is a next-generation 1 year continuous glucose monitoring device designed to be used in patients aged 18 years or older with type 1 or type 2 diabetes.

In September 2024, Abbott announced the availability of Lingo, a prescription-free continuous glucose monitoring device in the U.S. market. Lingo system is based on Abbott's FreeStyle Libre continuous glucose monitoring technology and consists of a biosensor and a mobile app.

In January 2024, Fitbit and Quest Diagnostics have partnered to study the use of wearable devices to improve metabolic health, which affects the risk of developing diseases like diabetes and heart disease. The Wearables for Metabolic Health (WEAR-ME) pilot study will combine behavioral and biometric data from Fitbit devices with Quest Diagnostics' laboratory tests to enhance metabolic health assessment and management, aiding disease prevention.

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.